Separation, dissociation and/or disaggregation of cells using shockwaves or mechanical impacts
Inventors
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Methods provided by the present disclosure utilize extracorporeal shockwaves, mechanical impacts and/or principles of lithotripsy to break up a tissue sample into smaller fragments—clusters of cells and/or single cells—after which a desired cellular fraction can be isolated from the sample. Devices provided by the present disclosure deploy focused and/or directed shockwaves, and/or focused and directed mechanical impacts, to break apart a tissue sample. The devices maintain the sample in a sterile, closed environment during exposure to the shockwaves or mechanical impacts. Therefore, the shockwaves and/or mechanical impacts are generated outside of a closed device and are transmitted through one or more walls of the device into its interior, where the sample is located.
Core Innovation
The disclosure relates to extracorporeal shockwave (ESW) and/or focused mechanical impacts that dissociate tissue into cell clusters and/or single cells for subsequent isolation of a desired cellular fraction, including a stromal vascular fraction and stem cells. The problem addressed is breaking down tissue into cell clusters and/or single cells while enabling isolation of the stromal vascular fraction and stem cells for downstream use. The described approach uses mechanical energy to disrupt tissue rather than relying on enzymatic breakdown as the primary mechanism for dissociation.
A key system aspect is a sterile, closed environment in which a shockwave/mechanical-energy source is kept outside a sealed device, while the energy is transmitted through the device walls to a processing container. The disclosure further describes mechanical impact generation via an impact arm on a controlled platform, including an impact-arm driven by a motor with articulation. The mechanical impacts are generated such that the impact arm makes physical contact with the processing container and does not physically contact the tissue.
The described processing architecture includes a processing container/cartridge configured to receive the tissue and enable force transmission for tissue breakdown, along with separation of the stromal vascular fraction from the tissue. The disclosure provides example comparison data between ESW disruption and collagenase digestion, reporting higher mesenchymal stem cell yields with ESW and quantifying yield ratios and an increase of about 164% over collagenase in the presented data.
Claims Coverage
The independent claim covers one inventive feature: a method of isolating a stromal vascular fraction from tissue using mechanical impacts generated by an impact arm, with the impact arm physically contacting the processing container but not physically contacting the tissue.
Isolating a stromal vascular fraction using container-contact mechanical impacts
Placing a tissue sample into a processing container; subjecting the tissue sample to force from mechanical impacts to break down the tissue; and separating the stromal vascular fraction from the tissue, wherein the mechanical impacts are generated by an impact arm that makes physical contact with the processing container.
Impact arm contacts the processing container without contacting the tissue
The impact arm does not physically contact the tissue while generating the mechanical impacts for breaking down the tissue and enabling separation of the stromal vascular fraction.
Overall, the claim set centers on container-contact mechanical impacts generated by an impact arm to break down tissue and separate the stromal vascular fraction, while preventing physical contact between the impact arm and the tissue.
Stated Advantages
Higher mesenchymal stem cell yields with ESW than collagenase digestion, including an increase of about 164% over collagenase in the presented data.
Documented Applications
Isolation of a stromal vascular fraction from tissue, including preparation for isolating stem cells.
Interested in licensing this patent?